Gold Standards in Pharmacovigilance Manfred HaubenJeffrey K. Aronson Current Opinion 21 November 2012 Pages: 645 - 655
Physician Response to Patient Reports of Adverse Drug Effects Beatrice A. GolombJohn J. McGrawJoel E. Dimsdale Short Communication 21 November 2012 Pages: 669 - 675
Allergic Reactions to Medicines Derived from Pelargonium Species Hugo J. de BoerUlrich HagemannRonald H. B. Meyboom Short Communication 21 November 2012 Pages: 677 - 680
A Modified Prescription-Event Monitoring Study to Assess the Introduction of Seretide Evohaler™ in England Michael J. PerrioLynda V. WiltonSaad A. W. Shakir Original Research Article 21 November 2012 Pages: 681 - 695
Telithromycin Use and Spontaneous Reports of Hepatotoxicity David D. DoreJulia R. DiBelloKate L. Lapane Original Research Article 21 November 2012 Pages: 697 - 703
Incidence of Allergic Reactions Associated with Antibacterial Use in a Large, Managed Care Organisation Catherine B. JohannesNajat ZiyadehGerald Faich Original Research Article 21 November 2012 Pages: 705 - 713
Criteria Revision and Performance Comparison of Three Methods of Signal Detection Applied to the Spontaneous Reporting Database of a Pharmaceutical Manufacturer Yasuyuki MatsushitaYasufumi KurodaIsao Yoshimura Original Research Article 21 November 2012 Pages: 715 - 726
Drug-Induced Endocrine and Metabolic Disorders Chaker Ben SalemRaoudha SlimKamel Bouraoui Correspondence 21 November 2012 Pages: 727 - 728
The Authors’ Reply Ronald C. W. MaAlice P. S. KongJuliana C. N. Chan Correspondence 21 November 2012 Pages: 728 - 729